CVM si aeaissctod thwi tgncieinf ognar rpanlatnst se.attnpi CMV is tmsntreitda iva ulexas ot,cncta ongar latsn,nartp ro eycrltvail avi enc.tlpaa tRatevoacnii fo MCV corusc ni eht uss.nedismpumpreo
nOarg anrsttanpl iteastnp era ta an aescrined skir fo CMV anumeniop.
eh saw renve nveig cinicorlvag - i deus that sa a leuc rove transalnpt nojeetirc
hWy dowlu hsti otn eb ucate asnpttlarn nirecjtoe ngdelai to ?RSAD ehT eneictinar is etlvede,a dna I see nay ornaes hwy ti wdlou eb ldetavee obedyn jcneeroti
via @sammyj98 via UpToDate:
Universal prophylaxis with valganciclovir or ganciclovir is typically given to patients at risk for cytomegalovirus (CMV) reactivation (eg, seropositive recipients and those with seropositive donors). The duration of therapy often depends on the type of organ transplanted, the risk status of the patient, and individual institutional practice. Some transplant centers prefer to use a pre-emptive approach (eg, routine CMV viral load monitoring within initiation of treatment when reactivation becomes evident) for specific patient populations.
submitted by ∗amorah(115)
It can be re-accessed by making a purchase.
Purchase your membership here
$279$49rvFee t-;g& erul tuo fetl ruactvlrine ruilefa -MTMS XP rplphaoyxis ;&-tg eulr otu yPoescuismnt i ecinvjeKyodri nartltpans but no WCBCRB/ in urnei ;>- rule otu tltanrpans etocjinre
nLiagev VCM nda itpaaylc tambuecoiymrc as eht ngirmiean two npoio.ts CVM is mreo ylkeli in a tlpantanrs nite.tap
$279$49